Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumors × zimberelimab × 30 days × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Adenocarcinoma Of Esophagus 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Kidney Neoplasms 1 Esophageal Neoplasms 1 Erythrocytosis, Familial, 4 1 Carcinoma, Transitional Cell 1

Interventions

pembrolizumab 2 atezolizumab 2 Cetuximab 2 tocilizumab 1 spartalizumab 1 ribociclib 1 pralsetinib 1 olaparib 1 lenvatinib 1 ipatasertib 1 inavolisib 1 entrectinib 1 encorafenib 1 dapagliflozin 1 binimetinib 1 alectinib 1 Trastuzumab 1 Nivolumab 1 Immune Checkpoint Inhibitors 1 Bevacizumab 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡